XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022   37,555,565      
Beginning balance at Dec. 31, 2022 $ 154,007 $ 38 $ 502,712 $ 1,575 $ (350,318)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon vesting of restricted stock units (in shares)   66,895      
Issuance of common stock upon exercise of stock options (in shares)   23,006      
Issuance of common stock upon exercise of stock options 46   46    
Issuance of shares pursuant to employee stock purchase plan (in shares)   85,210      
Issuance of shares pursuant to employee stock purchase plan 676   676    
Change in shares subject to repurchase 56   56    
Stock-based compensation expense 4,764   4,764    
Currency translation adjustment 72     72  
Change in unrealized (losses) gains on marketable securities 173     173  
Net loss (15,860)       (15,860)
Ending balance (in shares) at Mar. 31, 2023   37,730,676      
Ending balance at Mar. 31, 2023 143,934 $ 38 508,254 1,820 (366,178)
Beginning balance (in shares) at Dec. 31, 2022   37,555,565      
Beginning balance at Dec. 31, 2022 154,007 $ 38 502,712 1,575 (350,318)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Currency translation adjustment 242        
Change in unrealized (losses) gains on marketable securities 139        
Net loss (32,055)        
Ending balance (in shares) at Jun. 30, 2023   38,016,671      
Ending balance at Jun. 30, 2023 133,952 $ 38 514,331 1,956 (382,373)
Beginning balance (in shares) at Mar. 31, 2023   37,730,676      
Beginning balance at Mar. 31, 2023 143,934 $ 38 508,254 1,820 (366,178)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon vesting of restricted stock units (in shares)   222,598      
Issuance of common stock upon exercise of stock options (in shares)   63,503      
Issuance of common stock upon exercise of stock options 139   139    
Change in shares subject to repurchase 47   47    
Repurchase of early exercised common stock options (in shares)   (106)      
Stock-based compensation expense 5,891   5,891    
Currency translation adjustment 170     170  
Change in unrealized (losses) gains on marketable securities (34)     (34)  
Net loss (16,195)       (16,195)
Ending balance (in shares) at Jun. 30, 2023   38,016,671      
Ending balance at Jun. 30, 2023 $ 133,952 $ 38 514,331 1,956 (382,373)
Beginning balance (in shares) at Dec. 31, 2023 38,516,383 38,516,383      
Beginning balance at Dec. 31, 2023 $ 118,315 $ 39 526,797 2,640 (411,161)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon vesting of restricted stock units (in shares)   177,610      
Issuance of common stock upon exercise of stock options (in shares)   28,116      
Issuance of common stock upon exercise of stock options 57   57    
Issuance of shares pursuant to employee stock purchase plan (in shares)   90,066      
Issuance of shares pursuant to employee stock purchase plan 808   808    
Stock-based compensation expense 5,744   5,744    
Currency translation adjustment (549)     (549)  
Change in unrealized (losses) gains on marketable securities (128)     (128)  
Net loss (13,749)       (13,749)
Ending balance (in shares) at Mar. 31, 2024   38,812,175      
Ending balance at Mar. 31, 2024 $ 110,498 $ 39 533,406 1,963 (424,910)
Beginning balance (in shares) at Dec. 31, 2023 38,516,383 38,516,383      
Beginning balance at Dec. 31, 2023 $ 118,315 $ 39 526,797 2,640 (411,161)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares) 39,466        
Currency translation adjustment $ (509)        
Change in unrealized (losses) gains on marketable securities (158)        
Net loss $ (29,075)        
Ending balance (in shares) at Jun. 30, 2024 39,151,861 39,151,861      
Ending balance at Jun. 30, 2024 $ 101,184 $ 39 539,408 1,973 (440,236)
Beginning balance (in shares) at Mar. 31, 2024   38,812,175      
Beginning balance at Mar. 31, 2024 110,498 $ 39 533,406 1,963 (424,910)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon vesting of restricted stock units (in shares)   328,336      
Issuance of common stock upon exercise of stock options (in shares)   11,350      
Issuance of common stock upon exercise of stock options 22   22    
Stock-based compensation expense 5,980   5,980    
Currency translation adjustment 40     40  
Change in unrealized (losses) gains on marketable securities (30)     (30)  
Net loss $ (15,326)       (15,326)
Ending balance (in shares) at Jun. 30, 2024 39,151,861 39,151,861      
Ending balance at Jun. 30, 2024 $ 101,184 $ 39 $ 539,408 $ 1,973 $ (440,236)